|
|
Volumn , Issue , 2014, Pages e132-e139
|
|
Alpha-emitter radium-223 in the management of solid tumors: current status and future directions
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
RADIOISOTOPE;
RADIUM;
RADIUM CHLORIDE RA 223;
BONE NEOPLASMS;
BREAST NEOPLASMS;
FEMALE;
HUMAN;
MALE;
PATHOLOGY;
PHASE 3 CLINICAL TRIAL (TOPIC);
PROSTATIC NEOPLASMS, CASTRATION-RESISTANT;
SECONDARY;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
BONE NEOPLASMS;
BREAST NEOPLASMS;
CLINICAL TRIALS, PHASE III AS TOPIC;
FEMALE;
HUMANS;
MALE;
PROSTATIC NEOPLASMS, CASTRATION-RESISTANT;
RADIOISOTOPES;
RADIUM;
TREATMENT OUTCOME;
|
|
EID: 84921343437
PISSN: None
EISSN: 15488756
Source Type: Journal
DOI: 10.14694/EdBook_AM.2014.34.e132 Document Type: Review |
|
Times cited : (17)
|
|
References (0)
|